0001104659-22-100803.txt : 20220916 0001104659-22-100803.hdr.sgml : 20220916 20220916160213 ACCESSION NUMBER: 0001104659-22-100803 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220914 FILED AS OF DATE: 20220916 DATE AS OF CHANGE: 20220916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berrey M Michelle CENTRAL INDEX KEY: 0001397329 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 221248079 MAIL ADDRESS: STREET 1: 303A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08450 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 305 MADISON AVENUE CITY: MORRISTOWN STATE: NJ ZIP: 07960 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 305 MADISON AVENUE CITY: MORRISTOWN STATE: NJ ZIP: 07960 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 4 1 tm2225991-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-09-14 0 0001270073 INTERCEPT PHARMACEUTICALS, INC. ICPT 0001397329 Berrey M Michelle C/O INTERCEPT PHARMACEUTICALS, INC. 305 MADISON AVENUE MORRISTOWN NJ 07960 0 1 0 0 President, R&D and CMO Common Stock 2022-09-14 4 F 0 1246 17.14 D 71188 D Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person. /s/ Rocco Venezia, as attorney-in-fact 2022-09-16